This project will provide an estimate of the direct and indirect costs of ADHD in Canada. The peer-reviewed report will be used by the partner organization to appeal to the different levels of government to publicly fund ADHD treatment in Canada. An existing model, developed by Takeda Pharmaceuticals, will be adjusted to the Canadian context. […]
Read More